Financière de Tubize SA (EBR:TUB)
Belgium · Delayed Price · Currency is EUR 229.80
+2.20 (0.97%)
Oct 30, 2026, 5:35 PM CET
Financière de Tubize Market Cap
Financière de Tubize has a market cap or net worth of €10.23 billion as of October 30, 2026. It is the 1,904th most valuable company in the world and the 8th biggest in Belgium. Its market cap has increased by 4.45% in one year.
Market Cap
10.23B
Enterprise Value
10.18B
Revenue
n/a
Global Rank
Country Rank
#8 Belgium
PE Ratio
103.94
ChartMarket Cap Chart
Since April 16, 2001, Financière de Tubize's market cap has increased from 1.37B to 10.23B, an increase of 645.73%. That is a compound annual growth rate of 8.18%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 10.23B | 9.95% |
| Dec 31, 2025 | 9.30B | 46.98% |
| Dec 31, 2024 | 6.33B | 98.33% |
| Dec 29, 2023 | 3.19B | 1.27% |
| Dec 30, 2022 | 3.15B | -21.59% |
| Dec 31, 2021 | 4.02B | 9.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| UCB SA | 51.57B |
| argenx SE | 49.82B |
| Onward Medical | 156.79M |
| Hyloris Pharmaceuticals | 102.20M |
| European Medical Solutions | 16.76M |
| Celyad Oncology | 9.40M |
| BioSenic | 1.31M |
| Oxurion NV | 84.44K |